ClinicalTrialsFinder

Anaplastic Lymphoma Kinase (ALK) Positive Clinical Trials in Barcelona

1 recruitingBarcelona, Spain

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer (NSCLC)Anaplastic Lymphoma Kinase (ALK) Positive
Astellas Pharma Global Development, Inc.40 enrolled15 locationsNCT07140016